Position in BBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$297,920
New position
Shares Held
4,000
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#317
of 467 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026IHT Wealth Management, LLC holds $1,928,853 across 7 Biotechnology names. BBIO ranks #4 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,655 | $822,088 | |
| 2 | TLX |
Telix Pharmaceuticals Ltd
|
32,295 | $372,361 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
557 | $347,311 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
This page
|
4,000 | $297,920 | |
| 5 | GERN |
Geron Corp
|
35,250 | $45,120 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
10,704 | $39,283 | |
| 7 | MREO |
Mereo BioPharma Group plc
|
15,000 | $4,770 |
All Filings in BBIO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $297,920 | 4,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||